BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12001739)

  • 1. [Trends in the post-genomic pharmacological research].
    Wei EQ; Shen JZ
    Sheng Li Ke Xue Jin Zhan; 2002 Jan; 33(1):7-11. PubMed ID: 12001739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
    Wang SJ
    Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenomics and gene expression analysis. Functional genome research for individual application to patients].
    Kassack MU
    Med Monatsschr Pharm; 2003 May; 26(5):165-6. PubMed ID: 12784508
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic horizons--the human genome.
    Broder S; Caplan A; Evans WE
    J Am Pharm Assoc (Wash); 2002; 42(5 Suppl 1):S22-3. PubMed ID: 12296540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target practice: oncology drug development in the era of genomic medicine.
    Schilsky RL
    Clin Trials; 2007; 4(2):163-6; discussion 173-7. PubMed ID: 17456516
    [No Abstract]   [Full Text] [Related]  

  • 6. The human genome project: opportunities, challenges and consequences for population screening.
    Christodoulou J
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():234-8. PubMed ID: 15906744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of genomic tools to colorectal cancer therapeutics.
    Auman JT; McLeod HL
    Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.
    Anderson GD
    J Womens Health (Larchmt); 2005; 14(1):19-29. PubMed ID: 15692274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of whole-genome association studies: future applications at the bedside.
    Motsinger AA; Ritchie MD; Dobrin SE
    Expert Rev Mol Diagn; 2006 Jul; 6(4):551-65. PubMed ID: 16824029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and ethnicity in the era of emerging pharmacogenomics.
    Harty L; Johnson K; Power A
    J Clin Pharmacol; 2006 Apr; 46(4):405-7. PubMed ID: 16554447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current bioinformatics tools in genomic biomedical research (Review).
    Teufel A; Krupp M; Weinmann A; Galle PR
    Int J Mol Med; 2006 Jun; 17(6):967-73. PubMed ID: 16685403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research strategy for understanding neuronal plasticity and degeneration].
    Takeda M; Okochi M; Sugaya K; De-Maw C; Hashimoto R; Kuroda S; Shinosaki K; Kudo T; Tanaka T; Cacabelos R
    Seishin Shinkeigaku Zasshi; 2003; 105(1):43-6. PubMed ID: 12701211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenomics: way to individual therapy].
    Piruzian AL
    Eksp Klin Farmakol; 2005; 68(5):59-67. PubMed ID: 16277215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacogenomics primer.
    Court MH
    J Clin Pharmacol; 2007 Sep; 47(9):1087-103. PubMed ID: 17664254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging the gap: ageing, pharmacokinetics and pharmacodynamics.
    Burton DG; Allen MC; Bird JL; Faragher RG
    J Pharm Pharmacol; 2005 Jun; 57(6):671-9. PubMed ID: 15969921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.